AtriCure Total Stockholder Equity vs Net Receivables Analysis
ATRC Stock | USD 36.16 0.01 0.03% |
AtriCure financial indicator trend analysis is way more than just evaluating AtriCure prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AtriCure is a good investment. Please check the relationship between AtriCure Total Stockholder Equity and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
Total Stockholder Equity vs Net Receivables
Total Stockholder Equity vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AtriCure Total Stockholder Equity account and Net Receivables. At this time, the significance of the direction appears to have almost identical trend.
The correlation between AtriCure's Total Stockholder Equity and Net Receivables is 0.9. Overlapping area represents the amount of variation of Total Stockholder Equity that can explain the historical movement of Net Receivables in the same time period over historical financial statements of AtriCure, assuming nothing else is changed. The correlation between historical values of AtriCure's Total Stockholder Equity and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Stockholder Equity of AtriCure are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Total Stockholder Equity i.e., AtriCure's Total Stockholder Equity and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.9 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Net Receivables
Most indicators from AtriCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.78, whereas Enterprise Value Over EBITDA is projected to grow to (192.48).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 205.9M | 245.9M | 300.4M | 315.4M | Total Revenue | 274.3M | 330.4M | 399.2M | 419.2M |
AtriCure fundamental ratios Correlations
Click cells to compare fundamentals
AtriCure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AtriCure fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Total Stockholder Equity | 247.3M | 412.4M | 483.8M | 456.8M | 466.2M | 489.5M | |
Retained Earnings | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (357.1M) | (339.2M) | |
Other Assets | 705K | 16.5M | 955K | 2.0M | 1.0 | 0.95 | |
Common Stock Shares Outstanding | 37.6M | 42.1M | 46.0M | 45.7M | 46.3M | 24.2M | |
Liabilities And Stockholders Equity | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Other Stockholder Equity | 529.7M | 742.4M | 764.8M | 787.4M | 824.2M | 865.4M | |
Total Liab | 310.5M | 302.1M | 131.6M | 128.7M | 147.8M | 80.4M | |
Other Current Liab | 32.8M | 28.5M | 34.6M | 36.4M | 44.7M | 46.9M | |
Total Current Liabilities | 49.9M | 49.1M | 56.4M | 58.4M | 74.6M | 78.3M | |
Accounts Payable | 14.9M | 12.7M | 18.6M | 19.9M | 27.4M | 28.7M | |
Cash | 28.5M | 41.9M | 43.7M | 58.1M | 84.3M | 88.5M | |
Inventory | 29.4M | 35.0M | 39.0M | 45.9M | 67.9M | 71.3M | |
Other Current Assets | 3.9M | 4.3M | 5.0M | 5.5M | 8.6M | 9.0M | |
Common Stock | 40K | 45K | 46K | 47K | 48K | 28.1K | |
Property Plant Equipment | 32.6M | 28.3M | 36.2M | 42.6M | 49.0M | 51.5M | |
Property Plant And Equipment Net | 36.7M | 30.2M | 36.2M | 42.6M | 46.8M | 49.1M | |
Net Debt | 47.9M | 32.1M | 32.0M | 11.0M | (9.8M) | (9.3M) | |
Non Current Assets Total | 414.7M | 407.8M | 419.2M | 370.2M | 347.7M | 365.1M | |
Non Currrent Assets Other | 705K | 440K | 955K | 2.0M | 2.2M | 2.3M | |
Cash And Short Term Investments | 81.8M | 244.2M | 119.1M | 121.1M | 137.3M | 144.1M | |
Net Receivables | 28.0M | 23.1M | 33.0M | 42.7M | 52.5M | 55.1M | |
Common Stock Total Equity | 40K | 45K | 46K | 47K | 54.1K | 28.2K | |
Non Current Liabilities Total | 260.6M | 253.0M | 75.1M | 70.3M | 73.2M | 60.0M | |
Property Plant And Equipment Gross | 36.7M | 30.2M | 36.2M | 42.6M | 99.2M | 104.1M | |
Total Current Assets | 143.2M | 306.7M | 196.1M | 215.2M | 266.2M | 279.6M | |
Accumulated Other Comprehensive Income | (158K) | 312K | (948K) | (4.1M) | (993K) | (943.4K) | |
Short Long Term Debt Total | 76.4M | 74.0M | 75.6M | 69.1M | 74.5M | 78.2M | |
Long Term Debt | 59.6M | 53.4M | 59.7M | 56.8M | 60.6M | 63.6M | |
Short Term Investments | 53.3M | 202.3M | 75.4M | 63.0M | 53.0M | 40.8M | |
Short Term Debt | 2.2M | 6.7M | 1.8M | 2.1M | 2.5M | 2.2M | |
Intangible Assets | 129.9M | 128.2M | 43.0M | 39.3M | 64.0M | 36.9M | |
Other Liab | 186.4M | 187.4M | 1.2M | 1.2M | 1.4M | 1.3M | |
Net Tangible Assets | (117.3M) | 49.4M | 206.0M | 182.6M | 210.0M | 220.5M | |
Retained Earnings Total Equity | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (294.0M) | (308.7M) | |
Long Term Debt Total | 59.6M | 53.4M | 59.7M | 56.8M | 65.4M | 34.9M | |
Capital Surpluse | 529.7M | 742.4M | 764.8M | 787.4M | 905.5M | 470.9M | |
Non Current Liabilities Other | 201.0M | 199.6M | 15.4M | 13.5M | 1.2M | 1.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.83) | Revenue Per Share 9.564 | Quarterly Revenue Growth 0.179 | Return On Assets (0.04) | Return On Equity (0.08) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.